Showing results (91-100 of 131) with videos related to
Sort By:
Pageof 14
Antimicrobial Agents and Chemotherapy|December 1, 1992
In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycinK C Lamp, M J Rybak, E M Bailey, et al.DICP : the Annals of Pharmacotherapy|July 1, 1990
Coagulase-negative staphylococci: incidence, pathogenicity, and treatment in the 1990sE M Bailey, T D Constance, L M Albrecht, et al.Infection and Immunity|July 19, 2000
Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditisR C Mercier, M J Rybak, A S Bayer, et al.Antimicrobial Agents and Chemotherapy|March 1, 1996
Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infectionsA S Benko, D M Cappelletty, J A Kruse, et al.Antimicrobial Agents and Chemotherapy|October 1, 1987
Alanine aminopeptidase and beta 2-microglobulin excretion in patients receiving vancomycin and gentamicinM J Rybak, J J Frankowski, D J Edwards, et al.Journal of Clinical Pharmacology|May 23, 1998
A dose proportionality study of eprosartan in healthy male volunteersM C Chapelsky, D E Martin, D M Tenero, et al.Journal of Clinical Pharmacology|December 1, 1994
Pharmacokinetics of famciclovir in subjects with chronic hepatic diseaseS C Boike, M Pue, P R Audet, et al.Journal of Clinical Pharmacology|February 1, 1997
Eprosartan, an angiotensin II receptor antagonist, does not affect the pharmacodynamics of glyburide in patients with type II diabetes mellitusD E Martin, G S DeCherney, B E Ilson, et al.Antimicrobial Agents and Chemotherapy|June 20, 2000
Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetationsE Hershberger, E A Coyle, G W Kaatz, et al.Clinical Pharmacology and Therapeutics|November 14, 1997
Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteersD J Kazierad, D E Martin, R A Blum, et al.Pageof 14